Sandoz Paying $12.6M In Medicare Drug Pricing Dispute
Sandoz Inc. will hand over $12.6 million for allegedly reporting bogus drug prices in order to pump up its Medicare Part B reimbursements, the biggest civil monetary penalty ever involving such...To view the full article, register now.
Already a subscriber? Click here to view full article